T-cell malignancies with anti-CD19 chimeric antigen receptor T-cell therapy

Blood Adv. 2024 Aug 13;8(15):4144-4148. doi: 10.1182/bloodadvances.2024013248.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD19* / immunology
  • Humans
  • Immunotherapy, Adoptive* / adverse effects
  • Immunotherapy, Adoptive* / methods
  • Receptors, Antigen, T-Cell / genetics
  • Receptors, Antigen, T-Cell / immunology
  • Receptors, Chimeric Antigen* / immunology
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism

Substances

  • Antigens, CD19
  • Receptors, Chimeric Antigen
  • Receptors, Antigen, T-Cell